Guangdong Provincial Drug Trading Center issued a notice: 87 major varieties began to be purchased in volume

On March 7, the Guangdong Provincial Drug Trading Center issued the "Notice on Viewing the Information Related to the Guangdong Alliance's Common Diseases and Chronic Diseases Drugs for Centralized Procurement and Registration of Products in Volume".
The over-evaluation category/A purchase order/B purchase order has been planned in detail
.

The original text is as follows:

All relevant units:

In accordance with the relevant requirements and work arrangements of the "Guangdong Alliance's Common and Chronic Disease Drugs Centralized Procurement Document (GDYJYPDL202202)" (hereinafter referred to as the "Procurement Document"), the Guangdong Alliance is now carrying out the Guangdong Alliance's centralized procurement of common diseases and chronic diseases.
The relevant matters are notified as follows:

1.
View the content

(1) The relevant information form of the registered product that meets the application conditions (see Annex 1);

(2) Detailed list of over-evaluation/non-over-evaluation/A purchase order/B purchase order (see Annex 2)
.

2.
Time arrangement

From now until 17:30 on March 8, 2022
.

       3.
Other requirements

       (1) If you have any objection to viewing the information, please use the CA certificate to log in to the drug trading system within the specified time, fill in the feedback content through "Information Review/Feedback Management-Other Information Review/Feedback (Drugs)", and follow the requirements Upload the drug information review feedback form (see Annex 3 for the template) and related certification materials, and the feedback materials must be stamped with the official seal of the company page by page; if the feedback materials are not submitted within the specified time, it will be regarded as no objection, and the corresponding consequences will be borne by the company
.

       (2) If there is a situation listed in the "Procurement Documents" that "in the enterprises applying for the same product and the same competitive unit, the person in charge of the enterprise is the same person or there is a direct controlling or management relationship", the relevant enterprises are requested to make the declaration truthfully within the specified time, and the content of the declaration The name of the specific competitive unit involved, the specific relationship with the competitive unit enterprise (the person in charge of the enterprise is the same person/existing direct controlling relationship/existing management relationship) and relevant certification materials, please refer to the above point (1) for specific requirements and application methods
.

       (3) The content of the objection feedback materials submitted by the enterprise should be true, valid, clear and complete, targeted and unambiguous, and legal and valid evidence materials (including but not limited to certification documents stamped with the official seal of the provincial drug procurement department, winning bids) should be provided in accordance with laws and regulations.
Announcement on the website, notice of winning the bid or a complete screenshot of the official website, etc.
); objection feedback not submitted within the specified time, without providing corresponding supporting materials, or not submitted in accordance with the specified channels, will not be accepted in principle
.

       (4) The enterprise shall be responsible for the authenticity, validity and legitimacy of the submitted feedback materials, and all consequences arising from errors and omissions in the submitted materials shall be borne by the enterprise itself
.

       (5) Enterprises must truthfully declare relevant price information and shareholding (management) relationship.
For enterprises that falsely report, omit, conceal or submit false materials, once verified, they will be dealt with in accordance with the relevant provisions of the "Procurement Documents", and the corresponding responsibilities shall be The enterprise shall bear it by itself
.

       4.
Contact information

       (1) Online customer service on the official website of Guangdong Drug Trading Center
.

       (2) Consultation telephone: 020-38036183, 020-38036197 (working days: 8:30-12:00 14:00-17:30)
.

       Attachment: 1.

       2.

       3.

       Guangdong Drug Trading Center

       March 7, 2022

       Reference source: Cyberblue, Guangdong Drug Trading Center